Emory Selected to lead international drug discovery center for Alzheimer’s
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
-
-
NIH grant awarded to Georgia Tech researchers to develop mRNA-based drug to correct hematopoietic stem cells
On Oct. 1, 2019, the National Institutes of Health (NIH) awarded a $3.5 million grant to Georgia Institute…
-
The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccine
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
-
UPenn’s Center for Neurodegenerative Disease Research received an $18.1 million grant from NIH
On Sept. 30, 2019, UPenn’s Center for Neurodegenerative Disease Research (CNDR) announced it had received a grant expected…
-
UPenn created the first ‘bile duct-on-a-chip’
On Sept. 26, 2019, UPenn researchers led by Rebecca Wells, MD, announced they had created the first-ever ‘bile…
-
NIH awards contracts to Harvard T.H. Chan, Seattle Children’s and IDRI to advance tuberculosis immunology research
On Sept. 26, 2019, The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
-
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ Vaccine for Prevention of Smallpox and Mpox
On Sept. 24, 2019, Bavarian Nordic announced that the U.S. Food and Drug Administration (FDA) had approved JYNNEOS™…
-
Engineered killer T cells could provide long-lasting immunity against cancer
On Sept. 23, 2019, University of California, Los Angeles (UCLA) researchers announced they have harnessed the power of…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
-
Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment
On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…
-
UCLA clinical trial resulted in a brain implant to help restore visual perception to the blind
On Sept. 18, 2019, researchers from the University of California, Los Angeles (UCLA) announced developing a device geared…
-
UPenn and Novartis end 7-year R&D alliance, will narrow scope of collaboration
On Sept. 16, 2019, Healio reported the 7-year research and development alliance between Novartis and the University of…
-
Biotechnology | Diagnostics | Disease | Genomics | Medicine | Therapeutics
deCODE in Iceland agreed to sequence half of UK Biobank participants, largest ever undertaken
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
-
Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: Vitronectin
On Sept. 11, 2019, scientists at Sanford Burnham Prebys announced they had identified the long-sought structure of an…
-
IRBM signed agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies
On Sept. 9, 2019, IRBM announced the signing of a service and development agreement with The University of…
-
MouseLight Project mapped 1,000 neurons in the mouse brain
On Sept. 5, 2019, researchers at the Howard Hughes Medical Institute’s Janelia Research Campus announced that they had…
-
Penn researcher Virginia MY Lee, PhD, received $3 million Breakthrough Prize
On Sept. 5, 2019, Penn Professor Virginia M.Y. Lee, PhD received the Breakthrough Prize in Life Sciences, in…
-
Amgen acquired worldwide rights to psoriasis drug Otezla (apremilast) For $13.4 Billion
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezla (apremilast), the only oral, non-biologic treatment for psoriasis…
-
City of Port St Lucie Council voted to ﾠLeaseﾠ former VGTI Florida facility to the ﾠCleveland Clinic for $1 per year
On Aug. 26, 2019 , the City of Port St. Lucie Council voted 5 to 0 to ﾠleaseﾠ…
-
CDC released ACIP recommendations on use of influenza vaccines for the 2019-20 influenza season
On Aug. 23, 2019, the Centers for Disease Control and Prevention (CDC) released Immunization Practices Advisory Committee (ACIP)…
-
Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases
On Aug. 22, 2019, Chinook Therapeutics announced a $65 million Series A financing to discover and develop precision…
-
U of A researchers find elusive protein that could be key to eliminating neglected tropical diseases
On Aug. 22, 2019, University of Alberta announced they have found an important protein in the cells of…
-
Siteman Cancer Center received $15 million grant to support personalized leukemia therapies
On Aug. 21, 2019, Washington University investigators at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School…
-
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U Vienna, Charpentier
On Aug. 20, 2019, the eleventh U.S. CRISPR-Cas9 patent was awarded to University of California (UC), the University…
-
Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
-
CDC published updated ACIP recommendations for human papillomavirus vaccination of adults
On Aug. 16, 2019, the Centers for Disease Control and Prevention (CDC) announced that vaccination against human papillomavirus…
-
Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer
On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…
-
Biotechnology | Disease | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Therapeutics
CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
-
Siteman Cancer Center awarded $7.8 million to expand clinical trials access
On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…
-
Sylvester Comprehensive Cancer Center announced it had received NCI designation
On Jul. 29, 2019, Sylvester Comprehensive Cancer Center announced it had achieved National Cancer Institute (NCI) designation, becoming…
